Background & Aims Bacterial infections affect survival of patients with cirrhosis. Hospital-
acquired bacterial infections present a growing healthcare problem because of the …

Cirrhosis is an immune dysfunction state, and as such, patients with cirrhosis are susceptible
to bacterial, fungal, and viral infections. Because of infection, these patients have a …

Liver transplantation (LT) has emerged as an effective therapy for severe forms of acute on
Chronic Liver Failure (ACLF), an entity characterized by the development of multiorgan …

Intensive care unit (ICU) admission is frequently required in patients with decompensated
cirrhosis for organ support. This entity, known as acute-on-chronic liver failure (ACLF), is …

Patients with cirrhosis show an increased susceptibility to infection due to disease-related
immune-dysfunction. Bacterial infection therefore represents a common, often detrimental …

BACKGROUND Due to development of an immune-dysregulated phenotype, advanced liver
disease in all forms predisposes patients to sepsis acquisition, including by opportunistic …

Portal hypertension (PHT) is a clinical syndrome characterized by increased pressure in the
portal vein, the direct vascular connection between the gut and the liver. 1, 2 Liver cirrhosis …

Intensive care units (ICUs) are specialized environments dedicated to the management of
critically ill patients, who are particularly susceptible to drug-resistant bacteria. Among these …

Methods: Hospitalized patients with cirrhosis and bacterial/fungal infection were
prospectively enrolled at 46 centers. Clinical response to antibiotic treatment was defined …

Aim: Taxifolin (dihydroquercetin) is a natural bioactive flavonoid with antifungal, antiviral,
antibacterial, antioxidant, and anti-inflammatory properties, and is a valuable compound in …